Seeking Alpha

stockquestioner

stockquestioner
Send Message
View as an RSS Feed
View stockquestioner's Comments BY TICKER:
Latest  |  Highest rated
  • 3 Reasons Why Sanofi Rights (GCVRZ) Could Return 50% This Year [View article]
    Genzyme to feature Lemtrada at Congress of European Committee for Research for Treatment of MS 10/2-5 in Denmark.
    Sep 26 10:27 AM | 1 Like Like |Link to Comment
COMMENTS STATS
1 Comment
1 Like